[1]
B. Chapron, L. Risler, B. Phillips, C. Collins, K. Thummel, and D. Shen, “Reversible, Time-Dependent Inhibition of CYP3A-Mediated Metabolism of Midazolam and Tacrolimus by Telaprevir in Human Liver Microsomes”, J Pharm Pharm Sci, vol. 18, no. 1, pp. 101–111, Mar. 2015.